Mumbai-based pharma company JB Pharma is targeting 12-14 per cent revenue growth and a 26-28 per cent Ebitda margin in the short to medium term, with new launches expected to fuel growth in the ...
"There's a lot of things that come up that could change your life dramatically that just means that maybe there's a better plan for you," said Thiago Glieger.